• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers and Facilitators to Proactive Deprescribing in Saudi Hospitals: A Qualitative Study Using the Theoretical Domains Framework.沙特医院主动减药的障碍与促进因素:一项运用理论领域框架的定性研究
Healthcare (Basel). 2025 May 28;13(11):1274. doi: 10.3390/healthcare13111274.
2
Exploring challenges and enablers for community pharmacists using electronic prescriptions (Wasfaty) in Makkah region, Saudi Arabia: a qualitative study using the theoretical domains framework.探索沙特阿拉伯麦加地区社区药剂师使用电子处方(瓦斯法蒂)的挑战与促进因素:一项基于理论领域框架的定性研究
Front Med (Lausanne). 2024 Nov 7;11:1487852. doi: 10.3389/fmed.2024.1487852. eCollection 2024.
3
Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study.影响危重症成年患者抗精神病药物处方和停药实践的促进因素和障碍:一项定性研究。
J Gen Intern Med. 2023 Aug;38(10):2262-2271. doi: 10.1007/s11606-023-08042-5. Epub 2023 Apr 18.
4
Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.老年人群中苯二氮䓬类受体激动剂逐渐停药的障碍和促进因素:应用理论领域框架对定性和定量研究的系统综述。
Implement Sci. 2022 Jul 8;17(1):41. doi: 10.1186/s13012-022-01206-7.
5
Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.养老院老年人减药的障碍与促进因素:药剂师独立处方者基于理论的观点。
Res Social Adm Pharm. 2023 May;19(5):746-752. doi: 10.1016/j.sapharm.2023.01.013. Epub 2023 Jan 31.
6
Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians.欧洲医生调查中老年人停用苯二氮䓬类药物的障碍
JAMA Netw Open. 2025 Mar 3;8(3):e2459883. doi: 10.1001/jamanetworkopen.2024.59883.
7
Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.医护人员对终末期 Hospice 照护老年患者减药的看法:基于理论领域框架的定性研究。
Int J Pharm Pract. 2023 May 7;31(3):305-313. doi: 10.1093/ijpp/riad005.
8
Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.长期护理机构中减少药物使用的障碍和促进因素:定性证据的“最佳契合”框架综合分析。
Age Ageing. 2022 Jan 6;51(1). doi: 10.1093/ageing/afab250.
9
Enhancing medication management of older adults in Qatar: healthcare professionals' perspectives on challenges, barriers and enabling solutions.加强卡塔尔老年人的药物管理:医疗保健专业人员对挑战、障碍及可行解决方案的看法。
Ther Adv Drug Saf. 2024 Oct 7;15:20420986241272846. doi: 10.1177/20420986241272846. eCollection 2024.
10
Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.使用理论领域框架和能力、机会、动机和行为(COM-B)模型识别医院环境中减少苯二氮䓬类药物和镇静催眠药使用的障碍和促进因素:一项定性研究。
BMJ Open. 2023 Feb 22;13(2):e066234. doi: 10.1136/bmjopen-2022-066234.

本文引用的文献

1
Defining polypharmacy in older adults: a cross-sectional comparison of prevalence estimates calculated according to active ingredient and unique product counts.老年人多重用药的定义:根据活性成分和独特产品计数计算的患病率估计值的横断面比较。
Int J Clin Pharm. 2025 Jun;47(3):824-833. doi: 10.1007/s11096-025-01882-7. Epub 2025 Feb 15.
2
Deprescribing for nursing home residents with limited life expectancy: A qualitative study to identify barriers and enablers for healthcare professionals.为预期寿命有限的养老院居民减少用药:一项定性研究,以确定医疗保健专业人员面临的障碍和促成因素。
Geriatr Nurs. 2025 Mar-Apr;62(Pt B):1-11. doi: 10.1016/j.gerinurse.2025.01.049. Epub 2025 Feb 4.
3
Revolutionizing healthcare in KSA: A deep dive into clinical practice guideline development and implementation.沙特阿拉伯医疗保健领域的变革:深入探讨临床实践指南的制定与实施。
J Taibah Univ Med Sci. 2024 Dec 6;19(6):1202-1211. doi: 10.1016/j.jtumed.2024.11.010. eCollection 2024 Dec.
4
Pharmacists as independent prescribers in community pharmacy: A scoping review.社区药房中作为独立开方者的药剂师:一项范围综述。
Res Social Adm Pharm. 2025 Mar;21(3):142-153. doi: 10.1016/j.sapharm.2024.12.008. Epub 2024 Dec 21.
5
An integrative systematic review of nurses' involvement in medication deprescription in long-term healthcare settings for older people.针对护士在老年人长期医疗保健环境中参与药物停用的综合系统评价。
Ther Adv Drug Saf. 2024 Oct 16;15:20420986241289205. doi: 10.1177/20420986241289205. eCollection 2024.
6
The patient's perspectives of safe and routine proactive deprescribing in primary care for older people living with polypharmacy: a qualitative study.患者对老年人多病共存情况下常规安全主动精简用药的看法:一项定性研究。
BMC Geriatr. 2024 Oct 16;24(1):844. doi: 10.1186/s12877-024-05435-x.
7
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach.从医疗保健提供者、患者和照护者的角度看 2 型糖尿病和/或心血管疾病老年人的减药问题:挑战与支持积极主动方法的干预措施。
Expert Rev Clin Pharmacol. 2024 Aug;17(8):637-654. doi: 10.1080/17512433.2024.2378765. Epub 2024 Aug 12.
8
Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review.老年多重用药患者减药的态度和障碍:一项叙述性综述
NPJ Aging. 2024 Jan 23;10(1):6. doi: 10.1038/s41514-023-00132-2.
9
Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process.临床药师在精神卫生医院护理转接中的干预措施:聚焦于用药核对过程的病例报告
Front Psychiatry. 2023 Dec 27;14:1263464. doi: 10.3389/fpsyt.2023.1263464. eCollection 2023.
10
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.多学科药物审查和减少老年人用药干预措施在初级保健中为何能良好运行?一项实际审查和综合研究。
BMC Geriatr. 2023 Sep 25;23(1):591. doi: 10.1186/s12877-023-04256-8.

沙特医院主动减药的障碍与促进因素:一项运用理论领域框架的定性研究

Barriers and Facilitators to Proactive Deprescribing in Saudi Hospitals: A Qualitative Study Using the Theoretical Domains Framework.

作者信息

Alharthi Mohammed S

机构信息

Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.

出版信息

Healthcare (Basel). 2025 May 28;13(11):1274. doi: 10.3390/healthcare13111274.

DOI:10.3390/healthcare13111274
PMID:40508887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12155129/
Abstract

BACKGROUND

Polypharmacy, commonly defined as the use of five or more medications, is a growing concern in hospitals due to its association with adverse drug reactions, functional decline, and increased healthcare costs. Proactive deprescribing, which involves the planned discontinuation of unnecessary or potentially harmful medications, can optimise medication use. However, multiple barriers hinder its implementation. Saudi Arabia offers a unique context for deprescribing due to strong family roles in care, prevalent prescribing norms, and ongoing shifts toward value-based healthcare. This study explores the barriers and facilitators to proactive deprescribing among physicians in Saudi hospitals using the Theoretical Domains Framework (TDF). The TDF was used as it effectively identifies behavioural factors influencing clinical decision making in practice.

METHODS

Semi-structured interviews were conducted with 27 purposively sampled physicians experienced in managing polypharmacy. The interviews were transcribed and analysed thematically, with behavioural determinants identified and categorised according to the 14 domains of the Theory of Planned Behaviour (TDF).

RESULTS

Enablers included the availability of deprescribing guidelines, decision-support tools, interprofessional collaboration, and institutional backing. Physicians with specialised training expressed greater confidence in conducting deprescribing. Identified barriers included limited time, heavy workload, absence of standardised protocols, medico-legal concerns, resistance from patients and caregivers, and lack of formal training. These factors were categorised under seven key TDF domains, with Environmental Context and Resources, Social Influences, and Beliefs About Capabilities identified as the most influential in shaping physicians' deprescribing practices. Interactions between factors were observed, where supportive environments and collaborative teams helped offset key barriers such as time constraints, legal concerns, and patient resistance.

CONCLUSIONS

This study identified key behavioural and contextual factors influencing proactive deprescribing in Saudi hospital settings. Addressing barriers such as heavy workload, medico-legal concerns, and lack of standardised protocols through targeted interventions, including clinician training, institutional support, and multidisciplinary collaboration, may facilitate the integration of deprescribing into routine practice. The findings offer context-specific insights to inform future efforts aimed at improving medication safety and optimising prescribing in the Saudi healthcare system.

摘要

背景

多重用药通常被定义为使用五种或更多药物,由于其与药物不良反应、功能衰退及医疗成本增加相关,在医院中日益受到关注。主动减药,即有计划地停用不必要或有潜在危害的药物,可优化药物使用。然而,多种障碍阻碍了其实施。由于家庭在护理中的重要作用、普遍的处方规范以及向基于价值的医疗保健的持续转变,沙特阿拉伯为减药提供了独特的背景。本研究使用理论域框架(TDF)探讨沙特医院医生主动减药的障碍和促进因素。使用TDF是因为它能有效识别影响临床实践中决策的行为因素。

方法

对27名有多重用药管理经验的医生进行了目的抽样的半结构化访谈。访谈内容被转录并进行主题分析,行为决定因素根据计划行为理论(TDF)的14个领域进行识别和分类。

结果

促进因素包括减药指南的可用性、决策支持工具、跨专业协作和机构支持。接受过专门培训的医生在进行减药时表现出更大的信心。已识别的障碍包括时间有限、工作量大、缺乏标准化方案、医疗法律问题、患者和护理人员的抵触以及缺乏正规培训。这些因素被归类在TDF的七个关键领域下,其中环境背景与资源、社会影响以及对能力的信念被确定为对医生减药实践影响最大的因素。观察到了因素之间的相互作用,即支持性环境和协作团队有助于抵消诸如时间限制、法律问题和患者抵触等关键障碍。

结论

本研究确定了影响沙特医院环境中主动减药的关键行为和背景因素。通过有针对性的干预措施,包括临床医生培训、机构支持和多学科协作,解决诸如工作量大、医疗法律问题和缺乏标准化方案等障碍,可能有助于将减药纳入常规实践。研究结果提供了针对具体情况的见解,为未来旨在提高沙特医疗系统中药物安全性和优化处方的努力提供参考。